Tuesday, October 30, 2018 | 1:00 PM ET
The Government-University-Industry Research Roundtable (GUIRR) will host a webinar on the NINDS Neuroscience and NIH HEAL Biomarker Programs, with the Director, Mary Ann Pelleymounter. This webinar will provide an overview of the NINDS Neuroscience Biomarker Program along with general guidance for applications, and will highlight special biomarker initiatives for pain indications that are part of the NIH HEAL (Helping to End Addiction Long-Term) Initiative.
Biomarkers are essential tools for the discovery and development of therapeutics, allowing improved and better informed clinical trial design. Biomarkers facilitate the evaluation of therapeutic intervention on disease progression or recurrence, and are also being used to improve early diagnosis and therapeutic outcomes in cases where disease manifestation could be significantly weakened with treatment. However, few biomarkers progress beyond discovery to clinical practice, and robust, well-validated biomarkers for use in Phase II clinical trials remain scant. The goal of the NINDS Neuroscience Biomarker Program is to promote and develop strong candidate biomarkers of neurological disease toward clinical use. The NIH HEAL Biomarker initiative is intended to promote the discovery and validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-addictive pain therapeutics.
Learn more about the biomarkers programs and/or register for this Webinar.